Trademarkia Logo

Australia

AU$
Trademark Search
ATORVASTATIN LANDMARK PROGRAM

View On IPO.GOV.AU

ATORVASTATIN LANDMARK PROGRAM
Removed - Not renewed: Renewal fee not paid

Last updated on 23 Jan 2014

Owner Info

Pfizer Ireland Pharmaceuticals (a partnership between C.P. Pharmaceuticals International C.V. and Pfizer Overseas Pharmaceuticals)

Pottery Road

Dun Laoghaire, REPUBLIC OF IRELAND

Serial Number

960210 filed on 2 Jul 2003

Correspondent

Baker McKenzie

Tower One - International Towers Sydney,

L46,

SYDNEY, NSW, 2000 AUSTRALIA

ATORVASTATIN LANDMARK PROGRAM

Classification Information

Class [042]
Medical and scientific research, including in relation to conducting clinical trials; all the aforementioned services relating to Atorvastatin

Class [044]
Medical services including medical services in relation to clinical trials; all the aforementioned services relating to Atorvastatin; hygienic and bea Read More

Mark Details

Serial Number

960210

Registered On

2 Jul 2003

Renewal On

NA

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
23rd Jan 2014Trade Marks Removed from Register Published
16th Jan 2014Remove Trade Mark Non-Payment Renewal
16th Jul 2013Registration Status Change
2th May 2013Renewal Reminder correspondence sent
2th Jul 2012Registration Status Change
19th Apr 2006Amend Trade Mark Registration Particulars
5th May 2005Full Assignment - Subsequent Owner Registered Published
20th Apr 2005Full Assignment
18th Apr 2005Application for Assignment
19th Oct 2004Request for Certified Copies